View printer-friendly version |
Charles River Laboratories Completes Acquisition of Majority Ownership of Vital River
As part of the Vital River acquisition, Charles River will be the exclusive global partner for distribution of model creation services offered through Beijing Vital Star Biotechnology. The services of Beijing Vital Star Biotechnology include humanized model creation utilizing inducible pluripotent stem cell (iPS) and other technologies.
Charles River acquired the 75% ownership of Vital River for
approximately
Caution Concerning Forward-Looking Statements
This news release includes forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements may be identified by the use of words such as “anticipate,”
“believe,” “expect,” “will,” “may,” “estimate,” “plan,” “outlook,” and
“project” and other similar expressions that predict or indicate future
events or trends or that are not statements of historical matters.
Forward-looking statements include statements in this press release
regarding Charles River’s expectations with respect to the impact of
Vital River on the Company, its service offerings, net sales and
earnings, as well as Charles River’s future growth in the area of
research models and services in
About
Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
Source:
Investors:
Charles River Laboratories
Susan E. Hardy,
781-222-6190
Corporate Vice President, Investor Relations
susan.hardy@crl.com
or
Media:
Charles
River Laboratories
Amy Cianciaruso, 781-222-6168
Director,
Public Relations
amy.cianciaruso@crl.com